Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

JMV 2959

JMV 2959 is a growth hormone secretagogue receptor type 1a (GHS-R1a) antagonist with an IC50 of 32 nM.

Product Specifications

CAS Number

[925238-89-7]

UNSPSC

12352005

Target

GHSR

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Neurological Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/JMV_2959.html

Purity

99.91

Solubility

DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(N[C@@H](C1=NN=C(CCC2=CC=CC=C2)N1CC3=CC=C(OC)C=C3)CC4=CNC5=C4C=CC=C5)CN

Molecular Formula

C30H32N6O2

Molecular Weight

508.61

References & Citations

[1]Moulin A, et al. The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist. Amino Acids. 2013 Feb;44 (2) :301-14.|[2]Engel JA, et al. Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition. Psychopharmacology (Berl) . 2015 Dec;232 (23) :4285-92.|[3]Clifford PS, et al. Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addict Biol. 2012 Nov;17 (6) :956-63.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Peptides. 2022 May:151:170763.|Nat Commun. 2025 Mar 15;16 (1) :2568.|Univerzita Karlova v Praz. 2021 Oct.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-01 0.02 mg (E-Coli)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details
Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-02 0.02 mg (Yeast)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details
Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-03 0.1 mg (E-Coli)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details
Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-04 0.1 mg (Yeast)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details
Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-05 0.02 mg (Baculovirus)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details
Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)
MBS1339694-06 0.02 mg (Mammalian-Cell)

Recombinant Encephalitozoon cuniculi CDP-diacylglycerol--serine O-phosphatidyltransferase (PSS)

Ask
View Details